Ahmad Jawad, Bryce Cindy L, Cacciarelli Thomas, Roberts Mark S
Veterans Affairs Pittsburgh Healthcare System and University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
Ann Intern Med. 2007 May 15;146(10):707-13. doi: 10.7326/0003-4819-146-10-200705150-00004.
The Model for End-Stage Liver Disease (MELD) score has been used since February 2002 to allocate livers for transplantation from deceased donors according to medical need. Allocation based on MELD scores should ensure that sicker patients receive transplants first regardless of transplantation center volume.
To determine whether the MELD score at transplantation and waiting time of liver transplant recipients differs by transplantation center volume.
Analysis of the Organ Procurement and Transplantation Network database. Centers were classified according to the volume of transplantations performed in 2005: high (> or =100 transplantations), medium (50 to 99 transplantations), and low (<50 transplantations).
Transplantation centers in the United States.
20 075 transplant recipients between 27 February 2002 and 30 April 2006.
MELD scores and waiting times of liver transplant recipients.
Transplant recipients at high-volume centers had lower MELD scores (35.1% with MELD scores < or =18 vs. 22.7% and 27.0% at medium- and low-volume centers, respectively; P < 0.001), and the median MELD score was 22 compared with 24 at both medium- and low-volume centers. Despite having lower MELD scores, recipients at high-volume centers also experienced shorter waiting times (median waiting time, 69 days vs. 98 days and 94 days at medium-and low-volume centers, respectively; P < 0.001).
The definition of transplantation center volume was subjective. The recent implementation of MELD precluded analysis of differences in long-term outcomes related to waiting time or center volume.
The MELD scores and waiting time of liver transplant recipients differed by transplantation center volume. High-volume centers have shorter waiting times and perform more transplantations for less sick patients. The reasons for these differences are unclear but warrant further investigation.
自2002年2月起,终末期肝病模型(MELD)评分被用于根据医疗需求分配来自已故供体的肝脏以供移植。基于MELD评分的分配应确保病情较重的患者优先接受移植,而不考虑移植中心的移植量。
确定肝移植受者的移植时MELD评分和等待时间是否因移植中心的移植量而有所不同。
对器官获取与移植网络数据库进行分析。根据2005年的移植量对中心进行分类:高移植量(≥100例移植)、中等移植量(50至99例移植)和低移植量(<50例移植)。
美国的移植中心。
2002年2月27日至2006年4月30日期间的20075例肝移植受者。
肝移植受者的MELD评分和等待时间。
高移植量中心的移植受者MELD评分较低(MELD评分≤18的患者占35.1%,而中等移植量中心和低移植量中心分别为22.7%和27.0%;P<0.001),高移植量中心的MELD评分中位数为22,而中等移植量中心和低移植量中心均为24。尽管MELD评分较低,但高移植量中心的受者等待时间也较短(中位等待时间分别为69天,而中等移植量中心和低移植量中心分别为98天和94天;P<0.001)。
移植中心移植量的定义是主观的。MELD评分的近期实施使得无法分析与等待时间或中心移植量相关的长期结局差异。
肝移植受者的MELD评分和等待时间因移植中心的移植量而有所不同。高移植量中心的等待时间较短,且为病情较轻的患者进行更多的移植。这些差异的原因尚不清楚,但值得进一步研究。